Patents by Inventor Peter Guidon

Peter Guidon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6287606
    Abstract: Tissue and organ repair, healing and augmentation are enhanced by administering pharmaceutically acceptable group IIIa element-containing compounds in amounts sufficient to provide therapeutic levels of the elements. Group IIIa element-containing compounds mimic the beneficial biological effects of endogenous growth factors to induce cells responsible for repair, healing and augmentation of tissues and organs. Group IIIa element-containing compounds are suitable for a variety of applications such as wound healing, bone fracture repair, treatment of dermatologic conditions and successful bonding of implanted tissue grafts and prostheses.
    Type: Grant
    Filed: August 7, 1997
    Date of Patent: September 11, 2001
    Inventors: Richard Bockman, Peter Guidon
  • Patent number: 6165514
    Abstract: Tissue and organ repair, healing and augmentation are enhanced by administering pharmaceutically acceptable group IIIa element-containing compounds in amounts sufficient to provide therapeutic levels of the elements. Group IIIa element-containing compounds mimic the beneficial biological effects of endogenous growth factors to induce cells responsible for repair, healing and augmentation of tissues and organs. Group IIIa element-containing compounds are suitable for a variety of applications such as wound healing, bone fracture repair, treatment of dermatologic conditions and successful bonding of implanted tissue grafts and prostheses.
    Type: Grant
    Filed: December 29, 1998
    Date of Patent: December 26, 2000
    Assignee: The Hospital for Special Surgery
    Inventors: Richard Bockman, Peter Guidon
  • Patent number: 5686116
    Abstract: Tissue and organ repair, healing and augmentation are enhanced by administering pharmaceutically acceptable group IIIa element-containing compounds in amounts sufficient to provide therapeutic levels of the elements. Group IIIa element-containing compounds mimic the beneficial biological effects of endogenous growth factors to induce cells responsible for repair, healing and augmentation of tissues and organs. Group IIIa element-containing compounds are suitable for a variety of applications such as wound healing, bone fracture repair, treatment of dermatologic conditions and successful bonding of implanted tissue grafts and prostheses.
    Type: Grant
    Filed: June 5, 1995
    Date of Patent: November 11, 1997
    Assignee: New York Society For The Relief Of The Ruptured and Crippled, Maintaining The Hospital for Special Surgery
    Inventors: Richard Bockman, Peter Guidon
  • Patent number: 5556645
    Abstract: Skin, connective and support tissue repair is enhanced and augmented by administering pharmaceutically acceptable gallium-containing compounds in amounts sufficient to provide therapeutic levels of elemental gallium. Gallium-containing compounds mimic the effects of endogenous growth factors to induce cells within these tissues to produce new matrix by increasing the formation of critical structural matrix proteins responsible for skin, support and connective tissue repair, maintenance and augmentation. Gallium-containing compounds are suitable for a variety of applications in wound healing, including dermatologic and cosmetic skin repair, bone fracture repair and successful bonding of implanted tissue grafts and connective and support tissue prostheses.
    Type: Grant
    Filed: April 26, 1995
    Date of Patent: September 17, 1996
    Inventors: Richard Bockman, Peter Guidon